PL411499A1 - Kompozycja farmaceutyczna i/lub kosmetyczna do leczenia chorób i uszkodzeń skóry, sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej oraz jej zastosowanie - Google Patents

Kompozycja farmaceutyczna i/lub kosmetyczna do leczenia chorób i uszkodzeń skóry, sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej oraz jej zastosowanie

Info

Publication number
PL411499A1
PL411499A1 PL411499A PL41149915A PL411499A1 PL 411499 A1 PL411499 A1 PL 411499A1 PL 411499 A PL411499 A PL 411499A PL 41149915 A PL41149915 A PL 41149915A PL 411499 A1 PL411499 A1 PL 411499A1
Authority
PL
Poland
Prior art keywords
pharmaceutical
cosmetic composition
oil
injuries
treatment
Prior art date
Application number
PL411499A
Other languages
English (en)
Inventor
Andrzej Karol Furmaniak
Vladimir Platonov
Olga Platonov
Original Assignee
Andrzej Karol Furmaniak
Vladimir Platonov
Olga Platonov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrzej Karol Furmaniak, Vladimir Platonov, Olga Platonov filed Critical Andrzej Karol Furmaniak
Priority to PL411499A priority Critical patent/PL411499A1/pl
Priority to PCT/PL2016/000023 priority patent/WO2016144196A1/en
Publication of PL411499A1 publication Critical patent/PL411499A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Kompozycja farmaceutyczna i/lub kosmetyczna do zastosowania przy leczeniu chorób i uszkodzeń skóry o różnej etiologii, zawiera w odpowiednim stosunku bazę kosmetyczną oraz składniki czynne, takie jak: olej z awokado, olej z rokitnika, macerat z korzenia żywokostu lekarskiego, olej paczuli, olej neroli, olej z nagietka lekarskiego oraz witaminy B12. Inna kompozycja farmaceutyczna charakteryzuje się tym, że przy zachowaniu proporcji składników czynnych zawiera bazę farmaceutyczną w ilości powyżej 62,9% wag. do 95% wagowych i składniki czynne w ilości powyżej 37% wag. do 5% wag. Zgłoszenie zawiera także sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej polegający na tym, że dowolną bazę farmaceutyczną i/lub kosmetyczną umieszcza się w piecu ogrzanym do 35° - 40°C aż do upłynnienia i stale mieszając dodaje się pozostałe składniki aż do uzyskania jednorodności.
PL411499A 2015-03-07 2015-03-07 Kompozycja farmaceutyczna i/lub kosmetyczna do leczenia chorób i uszkodzeń skóry, sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej oraz jej zastosowanie PL411499A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL411499A PL411499A1 (pl) 2015-03-07 2015-03-07 Kompozycja farmaceutyczna i/lub kosmetyczna do leczenia chorób i uszkodzeń skóry, sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej oraz jej zastosowanie
PCT/PL2016/000023 WO2016144196A1 (en) 2015-03-07 2016-03-03 A pharmaceutical and/or cosmetic composition for treating skin diseases and damages, the process for preparing of the pharmaceutical and/or cosmetic composition and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL411499A PL411499A1 (pl) 2015-03-07 2015-03-07 Kompozycja farmaceutyczna i/lub kosmetyczna do leczenia chorób i uszkodzeń skóry, sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej oraz jej zastosowanie

Publications (1)

Publication Number Publication Date
PL411499A1 true PL411499A1 (pl) 2016-09-12

Family

ID=55750421

Family Applications (1)

Application Number Title Priority Date Filing Date
PL411499A PL411499A1 (pl) 2015-03-07 2015-03-07 Kompozycja farmaceutyczna i/lub kosmetyczna do leczenia chorób i uszkodzeń skóry, sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej oraz jej zastosowanie

Country Status (2)

Country Link
PL (1) PL411499A1 (pl)
WO (1) WO2016144196A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112972311A (zh) * 2021-04-12 2021-06-18 杭州易蓬科技有限公司 一种含有沙棘果油的抗敏舒缓组合物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106726972A (zh) * 2016-12-27 2017-05-31 鄂尔多斯市天骄资源发展有限责任公司 一种沙棘组合物及应用和由其制备形成的护肤膏和该护肤膏的制备方法
GB201805780D0 (en) * 2018-04-06 2018-05-23 Givaudan Sa Cosmetic composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187297B1 (en) * 1999-03-12 2001-02-13 Altai Cosmetics Ltd. Composition including sea buckthorn oil extract and antioxidant and / or a UV filter
US6576269B1 (en) * 2001-09-06 2003-06-10 Alexander Y. Korneyev Treating open skin lesions using extract of sea buckthorn
GB0426255D0 (en) * 2004-11-30 2004-12-29 Younger Skin Ltd Improvements in and relating to products for skin treatment
WO2013103944A1 (en) * 2012-01-07 2013-07-11 Aloe Baby, Llc Compositions and methods for treating skin conditions
RO128713B1 (ro) * 2012-01-16 2019-07-30 Zbuchea Andrei-Gheorghe Unguent pentru tratamentul arsurilor şi plăgilor, cu acţiune complexă, realizat exclusiv din produse naturale
WO2013149323A1 (en) * 2012-04-02 2013-10-10 Ntegrity Natural products for skin care
CN103385818A (zh) * 2012-05-11 2013-11-13 苏州纳特苏生物科技有限公司 一种晒后美白的复方精油
US20130319889A1 (en) * 2012-05-29 2013-12-05 Surgeons Skin Recovery Stick, Llc Skin care and restoration composition and methods

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112972311A (zh) * 2021-04-12 2021-06-18 杭州易蓬科技有限公司 一种含有沙棘果油的抗敏舒缓组合物
CN112972311B (zh) * 2021-04-12 2022-06-21 杭州易蓬科技有限公司 一种含有沙棘果油的抗敏舒缓组合物

Also Published As

Publication number Publication date
WO2016144196A1 (en) 2016-09-15

Similar Documents

Publication Publication Date Title
CL2019001160A1 (es) 1,2,4–triazolonas 2,4,5–trisustituidas.
CL2017000201A1 (es) Composiciones y métodos de uso para tratar trastornos metabólicos
SV2018005771A (es) Derivados de piridiniltriazol sustituidos con amida y usos de estos
MX2019014514A (es) Compuestos para tratar la enfermedad de huntington.
PH12018502634A1 (en) Topical compositions of apremilast
MX2018007022A (es) Metodos para tratar la enfermedad de huntington.
BR112016029041A8 (pt) uso de um inibidor de glutaminase, composição farmacêutica e kit farmacêutico
BR112018070852A2 (pt) composições de dissulfeto de selênio para uso no tratamento de disfunção das glândulas meibomianas
NZ631112A (en) Crystalline bromodomain inhibitors
MX2017010628A (es) Proteinas especificas novedosas para pioverdina y pioquelina.
BR112018069515A2 (pt) uso de masitinibe para tratamento de uma subpopulação de pacientes com esclerose lateral amiotrófica
BR112016021011A8 (pt) composição tópica e usos de um composto
BR112018014675A2 (pt) novos derivados de cianoindolina substituída como inibidores de nik
MX368970B (es) Formulacion de factor de crecimiento de fibroblastos 18 en hidrogeles de alginato/colageno.
MX2018016257A (es) Polipéptidos del receptor 3 del factor de crecimiento de fibroblastos solubles (sfgfr3) y usos de los mismos.
MX368814B (es) Composiciones que contienen azufre polimérico y usos de estas.
SG10201909412RA (en) Composition for suppressing muscular fatty change
BR112018012952A2 (pt) composições para higiene pessoal
MX2018002514A (es) Citotoxinas modificadas y su uso terapeutico.
PL411499A1 (pl) Kompozycja farmaceutyczna i/lub kosmetyczna do leczenia chorób i uszkodzeń skóry, sposób wytwarzania kompozycji farmaceutycznej i/lub kosmetycznej oraz jej zastosowanie
EA032654B9 (ru) [1,2,4]ТРИАЗОЛО[4,3-b]ПИРИДАЗИНЫ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
BR112019024667A2 (pt) Uso de um agente bioativo, e, de uma composição
BR112018003455A2 (pt) composição ou composição farmacêutica e uso da composição
MX2018008069A (es) Composicion lipida vegetal para promover el crecimiento del cabello, metodo para promover el crecimiento del cabello y uso de los lipidos vegetales.
BR112016014981A2 (pt) Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina